Clinical Trial Update: Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC) [Phase 4]

View source ↗

Summary

A Phase 4 multicenter study (REaCT-TNBC) evaluating an integrated consent model while comparing three standard-of-care regimens for triple-negative breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Breast Cancer | Phase 4 | Status: TERMINATED | Results posted: 2025-12-04